ID
INVG
Investing
The funds will be used to expand the U.S. and European reach of its FDA-cleared tinnitus treatment device, Lenire, including with the Department of Veterans Affairs.
The San Francisco-based digital musculoskeletal care company filed to go public on Monday and will list under the ticker symbol HNGE.
The MSK company will use the funds to expand its value-based care initiatives and advance its technology and clinical programs.
It is also expected to offer a new digital weight loss program.
Upcoming features include pre-chart summary creation.
The panelists highlighted digital health investments, innovation, interoperability and integration.
The 2025 Black Ambition Prize Competition will award more than $1 million to early-stage underrepresented entrepreneurs innovating in healthcare, AI and technology.
Launched from the Mayo Clinic Accelerator Program, the medical search platform uses AI to aggregate medical research.
The company has received 12 US FDA approvals.
The company offers services like sperm cryopreservation, fertility testing, testosterone treatments, and vasectomies.